Current Enzyme Inhibition

Aims & Scope

Current Enzyme Inhibition aims to publish original research, review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

"Current Enzyme Inhibition is an important review journal that describes recent developments in enzyme inhibition studies and is of great value to pharmaceutical and medicinal chemists."

Richard B. Silverman
Northwestern Univ., USA

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

The journal Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry publishes expert reviews, original research articles, drug clinical trial studies and special topic issues.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Current Cancer Drug Targets is high impact factor journal and essential reading for all pharmaceutical scientists involved in drug discovery and development.

Combinatorial Chemistry & High Throughput Screening is a high impact factor journal, having an impact factor 1.041, and is indexed by all major indexing agencies.

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Targets is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Drug Delivery journal is essential reading for all pharmaceutical scientists involved in drug design, development and delivery.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

The journal Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance.

Current Alzheimer Research publishes peer-reviewed reviews, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

CNS & Neurological Disorders - Drug Targets is a high impact factor journal and is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Drug Delivery & Formulation is essential reading for all researchers involved in the fields of drug delivery and formulation

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal Current Radiopharmaceuticals is essential reading for all the researchers involved in this field, and this journal is indexed by all the major indexing agencies

The journal Current Aging Science is essential reading for researchers, educators and physicians with interest in aging, age-related dementia and Alzheimer’s disease and longevity.

The Natural Products Journal a peer reviewed journal aims to publish all the latest and outstanding developments in natural products.

The journal Recent Patents on Biotechnology is of interest to a broad audience in its field, and it is indexed by all the major indexing agencies.

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

Current Regenerative Medicine publishes review and research articles, and guest edited thematic issues on important recent patents on regenerative medicine e.g. stem cells, gene therapy, tissue engineering, and tissue and organ regeneration. A selection of important and recent patents on regenerative medicine is also included in the journal. The journal is essential reading for all researchers involved in regenerative medicine. The journal also covers recent research (where patents have been registered) in fast emerging areas of regenerative medicine e.g. stem cells, gene therapy, tissue engineering, and tissue and organ regeneration.

Current Biomarkers publishes reviews, research articles, guest edited thematic issues, and reviews on biomarkers. The coverage includes novel biomarkers in basic, medical, environmental, and pharmaceutical research. . A selection of important and recent patents on biomarkers is also included in the journal. The journal is essential reading for all researchers involved in biomarker research and discovery. The journal also covers current research in fast emerging biomarker applications; discovery and validation for drug discovery, clinical development and molecular diagnostics.

Related E-Books

Bentham ebook::Application of Alternative Food-Preservation Technologies to Enhance Food Safety and Stability

Bentham ebook::Frontiers in Natural Product Chemistry

Bentham ebook::Rab GTPases and Membrane Trafficking

Bentham ebook::Recent Trends on QSAR in the Pharmaceutical Perceptions

Bentham ebook::Chemoinformatics: Directions Toward Combating Neglected Diseases

Bentham ebook::Sialobiology: Structure, Biosynthesis and Function Sialic Acid Glycoconjugates in Health and Disease

Bentham ebook::Methods to Determine Enzymatic Activity

Bentham ebook::Beta-glucan, Structure, Chemistry and Specific Application

Bentham ebook::Fundamentals of Systems Analysis and Modeling of Biosystems and Metabolism

Bentham ebook::Fungal Biotechnology for Biofuel Production

Bentham ebook::Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy

Bentham ebook::Frontiers in Clinical Drug Research – Diabetes and Obesity

Bentham ebook::Thyroid Ultrasonography and Fine Needle Aspiration Biopsy: A Practical Guide and Picture Atlas

Bentham ebook::New Aspects of the Renin Angiotensin System in Cardiovascular and Renal Diseases

Bentham ebook::Microcirculation and Insulin Resistance

Bentham ebook::The Role of Saliva Cortisol Measurement in Health and Disease

Bentham ebook::Epidemiology of Type 2 Diabetes

Bentham ebook::Phytotherapy in the Management of Diabetes and Hypertension

Bentham ebook::Physical Activity, Fitness, Nutrition and Obesity During Growth

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More

Welcome To
Current Enzyme Inhibition

About the Journal

Aims & Scope

Ranking and Category

Meet Our Regional Editor

Current Enzyme Inhibition, Vol. 14, Number 3, 2018

Virtual Screening and in vitro Antibacterial Activity for the Identification of Novel Inhibitors of Mycobacterium tuberculosis Methionine Aminopeptidase

Anti-Urease, Anti-Hyaluronidase, Antioxidant Properties of Some Zinc (II) Phthalocyanines

Inhibitory Effect of Phenolic Extracts of Four Algerian Atlas Saharan Plants on α-Glucosidase Activity

Celecoxib Modulates the Renin-Angiotensin System in the Adipose Tissue of Obese Mice

Sarcandra glabra Extract Protects against Scopolamine Induced Cognitive Deficits by Modulating Neuroinflammation and the Cholinergic System

α-amylase Inhibitory Effect and Antioxidant Activity of Cleome arabica Depending on Seasonal Variations

Investigation of the Inhibitory Effects of Human Carbonic Anhydrase I and Jack Bean Urease by Coumarin Derivates

Acknowledgements to Reviewers

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To Current Enzyme Inhibition

About the Journal

Aims & Scope

Ranking and Category

Meet Our Regional Editor

Current Enzyme Inhibition, Vol. 14, Number 3, 2018

Virtual Screening and in vitro Antibacterial Activity for the Identification of Novel Inhibitors of Mycobacterium tuberculosis Methionine Aminopeptidase

Anti-Urease, Anti-Hyaluronidase, Antioxidant Properties of Some Zinc (II) Phthalocyanines

Inhibitory Effect of Phenolic Extracts of Four Algerian Atlas Saharan Plants on α-Glucosidase Activity

Celecoxib Modulates the Renin-Angiotensin System in the Adipose Tissue of Obese Mice

Sarcandra glabra Extract Protects against Scopolamine Induced Cognitive Deficits by Modulating Neuroinflammation and the Cholinergic System

α-amylase Inhibitory Effect and Antioxidant Activity of Cleome arabica Depending on Seasonal Variations

Investigation of the Inhibitory Effects of Human Carbonic Anhydrase I and Jack Bean Urease by Coumarin Derivates

Acknowledgements to Reviewers

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To
Current Enzyme Inhibition